A systematic review of infliximab in the treatment of early rheumatoid arthritis

BACKGROUND: Several health authorities have recently revised the indication of infliximab (IFX) to include the treatment of early rheumatoid arthritis (RA). The aim of this systematic review of the literature was to appraise the efficacy, safety, and cost-effectiveness of early therapy with IFX. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Du Pan, Sophie Martin, Gabay, Cem, Finckh, Axel
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376089/
https://www.ncbi.nlm.nih.gov/pubmed/18473014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376089/
https://www.ncbi.nlm.nih.gov/pubmed/18473014

Ejemplares similares